<DOC>
	<DOCNO>NCT02489942</DOCNO>
	<brief_summary>Study investigate safety efficacy long-term daily use JARDIANCE® Tablets Japanese patient type 2 diabetes mellitus</brief_summary>
	<brief_title>Long Term Daily Use JARDIANCE® Tablets Japanese Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Empagliflozin</mesh_term>
	<criteria>Inclusion criterion : Male female Japanese patient type 2 diabetes mellitus never treat JARDIANCE® Tablets enrolment Exclusion criterion :</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>